CARMOT THERAPEUTICS
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases. They employ their patented technology, Chemotype Evolution, to address the fundamental causes of disease and speed the discovery of disease-modifying therapies. Carmot Therapeutics is headquartered in San Francisco, California and was founded in 2008.
CARMOT THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.carmot-therapeutics.us
Total Employee:
1+
Status:
Active
Contact:
5105279251
Email Addresses:
[email protected]
Total Funding:
234.85 M USD
Technology used in webpage:
SPF Google Apps For Business Unified Layer BlueHost BlueHost DNS BlueHost Mail
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Willett Advisors LLC
Willett Advisors LLC investment in Series D - Carmot Therapeutics
Deep Track Capital
Deep Track Capital investment in Series D - Carmot Therapeutics
The Column Group
The Column Group investment in Series D - Carmot Therapeutics
RA Capital Management
RA Capital Management investment in Series D - Carmot Therapeutics
Horizons Ventures
Horizons Ventures investment in Series D - Carmot Therapeutics
Horizons Ventures
Horizons Ventures investment in Series C - Carmot Therapeutics
The Column Group
The Column Group investment in Series C - Carmot Therapeutics
Amgen Ventures
Amgen Ventures investment in Series C - Carmot Therapeutics
The Column Group
The Column Group investment in Series B - Carmot Therapeutics
Horizons Ventures
Horizons Ventures investment in Series B - Carmot Therapeutics
Official Site Inspections
http://www.carmot-therapeutics.us Semrush global rank: 5.15 M Semrush visits lastest month: 1.57 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Carmot Therapeutics" on Search Engine
Carmot Therapeutics Announces Completion of Acquisition by …
BERKELEY, Calif., January 29, 2024 (GLOBE NEWSWIRE) — Carmot Therapeutics Inc. (Carmot), a clinical-stage biotechnology company dedicated to developing life-changing …See details»
Carmot Therapeutics Enters into Definitive Merger Agreement …
Dec 4, 2023 Carmot Therapeutics. – Roche to acquire Carmot for an upfront payment of $2.7 billion and the potential for $400 million in milestone payments –. – Carmot will join …See details»
Roche enters into a definitive merger agreement to …
Basel, 4 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc. …See details»
Carmot Therapeutics Announces Completion of …
BERKELEY, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Carmot Therapeutics Inc. (Carmot), a clinical-stage biotechnology company dedicated to developing life-changing …See details»
Carmot Therapeutics Announces Completion of Acquisition by …
BERKELEY, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Carmot Therapeutics Inc. (Carmot), a clinical-stage biotechnology company dedicated to developing life-changing …See details»
Carmot Therapeutics - Crunchbase Company Profile
Operating Status Active. Last Funding Type Series E. Legal Name Carmot Therapeutics Inc. Company Type For Profit. Contact Email [email protected]. Phone Number …See details»
Carmot Therapeutics Enters into Definitive Merger Agreement …
BERKELEY, Calif., December 3, 2023 (GLOBE NEWSWIRE) — Carmot Therapeutics Inc. (Carmot), a clinical-stage biotechnology company dedicated to developing life-changing …See details»
Carmot Therapeutics Enters Definitive Merger …
San Francisco – December 3, 2023 – Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for …See details»
Carmot Therapeutics Enters into Definitive Merger Agreement
BERKELEY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Carmot Therapeutics Inc. (Carmot), a clinical-stage biotechnology company dedicated to developing life-changing …See details»
Carmot Therapeutics Announces Significant Leadership Team …
Sep 21, 2022 BERKELEY, Calif.-- ( BUSINESS WIRE )--Carmot Therapeutics, Inc. (Berkeley, CA), a clinical-stage biotechnology company applying its proprietary drug …See details»
Carmot Therapeutics Announces that Preliminary Phase 1 …
BERKELEY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Carmot Therapeutics, Inc. (Carmot), a clinical-stage biotechnology company dedicated to developing life-changing …See details»
Carmot Therapeutics Announces Completion of Acquisition by …
BERKELEY, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Carmot Therapeutics Inc. (Carmot), a clinical-stage biotechnology company dedicated to developing life-changing …See details»
Carmot Therapeutics Raises $150 Million in Series E Equity …
BERKELEY, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Carmot Therapeutics, Inc., a clinical-stage biotechnology company developing disease-modifying therapies for …See details»
Roche acquires Carmot Therapeutics - 2023-12-03 - Crunchbase
Dec 3, 2023 Overview. Acquired Organization: Carmot Therapeutics Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological …See details»
Carmot Therapeutics - Funding, Financials, Valuation & Investors
Carmot Therapeutics. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Funding Rounds 8. Total Funding Amount. Unlock …See details»
Carmot Therapeutics Commenced Phase 2 Clinical Trial of Novel …
BERKELEY, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Carmot Therapeutics Inc. (Carmot), a clinical-stage biotechnology company dedicated to developing life-changing …See details»